Cardiometabolic Risk

Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...

Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.

In this Q and A, Robin Gal, MSPH, CCRA, Grazia Aleppo, MD, FACE, FACP, and Teresa McArther, MS, RD, CDES answer questions about their study that investigated the use of a virtual clinic to support...

Bruce Y. Lee, MD, MBA, and Marie C. Ferguson, MSPH, answer our questions about their study on the impact of following different solid food feeding guidelines on weight trajectories of infants.

Consultant360 spoke with Michael J. Wilkinson, MD, whose study found that 10-hour time-restricted eating may aid in the reversal and prevention of metabolic syndrome.

Is obesity a causal risk factor for aortic stenosis? Researcher, Børge G. Nordestgaard, MD, DMSc, sheds light by answering our questions about his team’s latest study.

Endocrinology Consultant spoke with James Rosenzweig, MD, chair of the task force that developed the Endocrine Society’s clinical practice guideline for the primary prevention of atherosclerotic...

Jonathan C. Hsu, MD, from the University of California San Diego, answers our questions about preventing stroke in a challenging patient population.

Brendan M. Everett, MD, MPH, from Harvard Medical School answers our questions about his session at the World Congress Insulin Resistance Diabetes & Cardiovascular Disease conference.